Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer
Clinical trial NCT06434077 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06434077
- Sponsor
- S.LAB (SOLOWAYS)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-20
- Primary completion
- 2026-09-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.